Dry Eye Syndrome Clinical Presentation

  • Author: C Stephen Foster, MD, FACS, FACR, FAAO; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Jan 25, 2012
 

History

Ocular irritation of dry sensation, burning, itching, pain, foreign body sensation, photophobia, and blurred vision are common in patients with dry eye. These symptoms are often exacerbated in smoky or dry environments, by indoor heating, or by excessive reading or computer use. These symptoms are quantified objectively in the Ocular Surface Disease Index (OSDI) questionnaire, which lists 12 symptoms and grades each on a scale of 1-4.

In KCS, symptoms tend to be worse toward the end of the day, with prolonged use of the eyes, or with exposure to extreme environmental conditions. Patients with meibomian gland dysfunction may complain of redness of the eyelids and conjunctiva, but, in these patients, the symptoms are worse on awakening in the morning.

Paradoxically, some patients with dry eye syndrome complain of too much tearing. When evidence of dry eye syndrome exists, this symptom often is explained by excessive reflex tearing due to severe corneal surface disease from the dryness.

Certain systemic medications also decrease tear production, such as antihistamines, beta-blockers, and oral contraceptives.

Past medical history may be significant for coexisting connective tissue disease, rheumatoid arthritis, or thyroid abnormalities. A thorough review of systems should be obtained, asking specifically about dry mouth.

Within the veteran population, a study found an increased incidence of dry eye syndrome in both men and women that was also strongly connected to cases of posttraumatic stress disorder and depression.[4]

Next

Physical

Signs of a dry eye include the following:

  • Bulbar conjunctival vascular dilation
  • Decreased tear meniscus
  • Irregular corneal surface
  • Decreased tear break-up time
  • Punctate epithelial keratopathy
  • Corneal filaments
  • Increased debris in the tear film
  • Conjunctival pleating
  • Superficial punctuate keratitis, with positive fluorescein staining
  • Mucous discharge
  • Corneal ulcers in severe cases

Symptoms often do not correlate with signs.

In severe cases, there may be an epithelial defect or a sterile corneal infiltrate or ulcer. Secondary infectious keratitis also can develop. Both sterile and infectious corneal perforations can occur.

Previous
Next

Causes

The International Dry Eye WorkShop (DEWS) recently developed a 3-part classification of dry eye, based on etiology, mechanisms, and disease stage.[1]

The classification system, which is updated as an etiopathogenic classification by the DEWS Subcommittees, formulated by the National Eye Institute (NEI)/Industry Dry Eye Workshop Report in 1995, distinguishes 2 main categories (or causes) of dry eye states, as follows: an aqueous deficiency state and an evaporative state.

  • Deficient aqueous production
    • Sjogren syndrome dry eye
      • Primary
      • Secondary
    • Non-Sjogren syndrome dry eye
      • Lacrimal gland deficiency
      • Lacrimal gland duct obstruction
      • Reflex hyposecretion
      • Systemic drugs
  • Evaporative
    • Intrinsic causes
      • Meibomian gland dysfunction
      • Disorders of lid aperture
      • Low blink rate
      • Drug action (eg, Accutane)
    • Extrinsic causes
      • Vitamin A deficiency
      • Topical drugs and preservatives
      • Contact lens wear
      • Ocular surface disease (eg, allergy)

Deficient aqueous production can be further classified as follows:

  • Non-Sjögren syndrome
    • Primary lacrimal gland deficiencies
      • Idiopathic
      • Age-related dry eye
      • Congenital alacrima (eg, Riley-Day syndrome)
      • Familial dysautonomia
    • Secondary lacrimal gland deficiencies
      • Lacrimal gland infiltration
      • Sarcoidosis
      • Lymphoma
      • AIDS
      • Graft vs host disease
      • Amyloidosis
      • Hemochromatosis
      • Lacrimal gland infectious diseases
      • HIV diffuse infiltrative lymphadenopathy syndrome
      • Trachoma
      • Systemic vitamin A deficiency (xerophthalmia) – Malnutrition, fat-free diets, intestinal malabsorption from inflammatory bowel disease, bowel resection, or chronic alcoholism
      • Lacrimal gland ablation
      • Lacrimal gland denervation
    • Lacrimal obstructive disease
      • Trachoma
      • Ocular cicatricial pemphigoid
      • Erythema multiforme and Stevens-Johnson syndrome
      • Chemical and thermal burns
      • Endocrine imbalance
      • Postradiation fibrosis
    • Medications – Antihistamines, beta-blockers, phenothiazines, atropine, oral contraceptives, anxiolytics, antiparkinsonian agents, diuretics, anticholinergics, antiarrhythmics, topical preservatives in eye drops, topical anesthetics, and isotretinoin
    • Reflex hyposecretion – Reflex sensory block and reflex motor block
      • Neurotrophic keratitis - Fifth nerve/ganglion section/injection/compression
      • Corneal surgery - Limbal incision (eg, extracapsular cataract extraction), keratoplasty, refractive surgery (eg, PRK, LASIK, RK)
      • Infective - Herpes simplex keratitis, herpes zoster ophthalmicus
      • Topical agents - Topical anesthesia
      • Systemic medications – Beta blockers, atropine-like drugs
      • Chronic contact lens wear
      • Diabetes
      • Aging
      • Trichloroethylene toxicity
      • Cranial nerve VII (CN VII) damage
      • Multiple neuromatosis
  • Sjögren syndrome
    • Primary (no associated connective tissue disease [CTD])
    • Secondary (associated CTD)
      • Rheumatoid arthritis
      • Systemic lupus erythematosus
      • Progressive systemic sclerosis (scleredema)
      • Primary biliary cirrhosis
      • Interstitial nephritis
      • Polymyositis and dermatomyositis
      • Polyarteritis nodosa
      • Hashimoto thyroiditis
      • Lymphocytic interstitial pneumonitis
      • Idiopathic thrombocytopenic purpura
      • Hypergammaglobulinemia
      • Waldenstrom macroglobulinemia
      • Wegener granulomatosis

Evaporative loss can be further classified as follows:

  • Intrinsic causes
    • Meibomian gland disease
      • Reduced number - Congenital deficiency, acquired meibomian gland dysfunction
      • Replacement - Distichiasis, distichiasis lymphedema syndrome, metaplasia
      • Meibomian gland dysfunction
        • Hypersecretory - Meibomian seborrhea
        • Hyposecretory - Retinoid therapy
        • Obstructive – Simple, primary or secondary to local disease (eg, anterior blepharitis), systemic disease (eg, acne rosacea, seborrheic dermatitis, atopy, ichthyosis, psoriasis), syndromes (eg, anhidrotic ectodermal dysplasia, ectrodactyly syndrome, Turner syndrome), and systemic toxicity (eg, 13-cis retinoic acid, polychlorinated biphenyls); or cicatricial, primary or secondary to local disease (eg, chemical burns, trachoma, pemphigoid, erythema multiforme, acne rosacea, VKC, AKC)
    • Low blink rate
      • Physiological phenomenon, such as during performance of tasks that require concentration (eg, working at a computer or a microscope)
      • Extrapyramidal disorder, such as Parkinson disease (decreasing dopaminergic neuron pool)
    • Disorders of eyelid aperture and eyelid/globe congruity
      • Exposure (eg, craniostenosis, proptosis, exophthalmos, high myopia)
      • Lid palsy
      • Ectropion
      • Lid coloboma
    • Drug action (eg, Accutane)
  • Extrinsic causes
    • Vitamin A deficiency
      • Development disorder of goblet cells
      • Lacrimal acinar damage
    • Topical drugs and preservatives (surface epithelial cell damage)
    • Contact lens wear
    • Ocular surface disease (eg, allergy)

A classification of dry eye on the basis of mechanisms includes tear hyperosmolarity and tear film instability.

For a classification of dry eye on the basis of severity, the Delphi Panel Report was adopted and modified as a third component of the DEWS.[1] See Table.

Table 1. Dry Eye Severity levels[1, 5] (Open Table in a new window)

Dry Eye Severity level1234 (Must have signs and symptoms.)
Discomfort, severity & frequencyMild and/or episodic; occurs under environmental stressModerate episodic or chronic, stress or no stressSevere frequent or constant without stressSevere and/or disabling and constant
Visual symptomsNone or episodic mild fatigueAnnoying and/or activity-limiting episodicAnnoying, chronic and/or constant, limiting activityConstant and/or possibly disabling
Conjunctival injectionNone to mildNone to mild+/–+/++
Conjunctival stainingNone to mildVariableModerate to markedMarked
Corneal staining (severity/location)None to mildVariableMarked centralSevere punctate erosions
Corneal/tear signsNone to mildMild debris, decreased meniscusFilamentary keratitis, mucus clumping, increased tear debrisFilamentary keratitis, mucus clumping, increased tear debris, ulceration
Lid/meibomian glandsMGD variably presentMGD variably presentFrequentTrichiasis, keratinization, symblepharon
TFBUT (sec)Variable≤10≤5Immediate
Schirmer score (mm/5 min)Variable≤10≤5≤2
Previous
 
 
Contributor Information and Disclosures
Author

C Stephen Foster, MD, FACS, FACR, FAAO  Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary; Founder and President, Ocular Immunology and Uveitis Foundation, Massachusetts Eye Research and Surgery Institution

C Stephen Foster, MD, FACS, FACR, FAAO is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Association of Immunologists, American College of Rheumatology, American College of Surgeons, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, American Uveitis Society, Association for Research in Vision and Ophthalmology, Massachusetts Medical Society, Royal Society of Medicine, and Sigma Xi

Disclosure: Nothing to disclose.

Coauthor(s)

Erdem Yuksel, MD  Fellow, Department of Ophthalmology, Massachusetts Eye Research and Surgery Institute, Medical School of Gazi University

Disclosure: Nothing to disclose.

Fahd Anzaar, MD  Fellow, Massachusetts Eye Research and Surgery Institute; Clinical Research and Education Coordinator, Ocular Immunology and Uveitis Foundation

Disclosure: Nothing to disclose.

Anthony S Ekong, MD  Consulting Staff, Department of Ophthalmology, Marshfield Clinic

Anthony S Ekong, MD is a member of the following medical societies: American Academy of Ophthalmology and American Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Jack L Wilson, PhD  Distinguished Professor, Department of Anatomy and Neurobiology, University of Tennessee Health Science Center College of Medicine

Jack L Wilson, PhD is a member of the following medical societies: American Association of Anatomists, American Association of Clinical Anatomists, and American Heart Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Christopher J Rapuano, MD  Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Institute

Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Cornea Society, Eye Bank Association of America, International Society of Refractive Surgery, and Pan-American Association of Ophthalmology

Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; RPS Ownership interest Other; EyeGate Pharma Consulting fee Consulting; Bausch & Lomb Honoraria Speaking and teaching; Bausch & Lomb Consulting; Merck Honoraria Speaking and teaching

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Dry Eye Workshop (DEWS) Committee. 2007 Report of the Dry Eye Workshop (DEWS). Ocul Surf. April 2007;5(2):65-204. [Full Text].

  2. Lambiase A, Micera A, Sacchetti M, et al. Alterations of tear neuromediators in dry eye disease. Arch Ophthalmol. Aug 2011;129(8):981-6. [Medline].

  3. Nien CJ, Massei S, Lin G, Nabavi C, Tao J, Brown DJ, et al. Effects of age and dysfunction on human meibomian glands. Arch Ophthalmol. Apr 2011;129(4):462-9. [Medline].

  4. Galor A, Feuer W, Lee DJ, et al. Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol. Sep 2011;152(3):377-384.e2. [Medline].

  5. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. Sep 2006;25(8):900-7. [Medline].

  6. Gilbard JP, Farris RL, Santamaria J 2nd. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol. Apr 1978;96(4):677-81. [Medline].

  7. Lemp MA, Bron AJ, Baudouin C, Benítez Del Castillo JM, Geffen D, Tauber J, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. May 2011;151(5):792-798.e1. [Medline].

  8. Ohba E, Dogru M, Hosaka E, et al. Surgical punctal occlusion with a high heat-energy releasing cautery device for severe dry eye with recurrent punctal plug extrusion. Am J Ophthalmol. Mar 2011;151(3):483-487.e1. [Medline].

  9. Mataftsi A, Subbu RG, Jones S, Nischal KK. The use of punctal plugs in children. Br J Ophthalmol. Jan 2012;96(1):90-2. [Medline].

  10. Baiza-Duran L, Medrano-Palafox J, Hernandez-Quintela E, Lozano-Alcazar J, Alaniz-de la O JF. A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome. Br J Ophthalmol. Oct 2010;94(10):1312-5. [Medline].

  11. Abelson MB. Dry eye, today and tomorrow. Review in Ophthalmology. 2000;11:132-34.

  12. American Academy of Ophthalmology. External disease and cornea. In: Section Seven: Basic & Clinical Science Course. American Academy of Ophthalmology; 2007-2008.

  13. Barabino S, Rolando M, Camicione P, et al. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. Mar 2003;22(2):97-101. [Medline].

  14. Bron AJ, Tiffany JM, Gouveia SM, et al. Functional aspects of the tear film lipid layer. Exp Eye Res. Mar 2004;78(3):347-60. [Medline].

  15. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. Nov 2004;88(11):1467-74. [Medline].

  16. Gilbard JP. Dry eye disorders. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Vol 2. WB Saunders Co; 2000:982-1000.

  17. Karadayi K, Ciftci F, Akin T, et al. Increase in central corneal thickness in dry and normal eyes with application of artificial tears: a new diagnostic and follow-up criterion for dry eye. Ophthalmic Physiol Opt. Nov 2005;25(6):485-91. [Medline].

  18. McCulley JP, Shine WE. The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res. Mar 2004;78(3):361-5. [Medline].

  19. Murube J, Nemeth J, Hoh H, et al. The triple classification of dry eye for practical clinical use. Eur J Ophthalmol. Nov-Dec 2005;15(6):660-7. [Medline].

  20. Ohashi Y, Dogru M, Tsubota K. Laboratory findings in tear fluid analysis. Clin Chim Acta. Jul 15 2006;369(1):17-28. [Medline].

  21. Perry HD, Donnenfeld ED. Dry eye diagnosis and management in 2004. Curr Opin Ophthalmol. Aug 2004;15(4):299-304. [Medline].

  22. Pflugfelder SC. Advances in the diagnosis and management of keratoconjunctivitis sicca. Curr Opin Ophthalmol. Aug 1998;9(4):50-3. [Medline].

  23. Stern ME, Gao J, Siemasko KF, et al. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. Mar 2004;78(3):409-16. [Medline].

  24. Tatlipinar S, Akpek EK. Topical ciclosporin in the treatment of ocular surface disorders. Br J Ophthalmol. Oct 2005;89(10):1363-7. [Medline].

  25. Yoon KC, Heo H, Im SK, et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. Jul 2007;144(1):86-92. [Medline].

  26. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res. May 2006;82(5):885-98. [Medline].

Previous
Next
 
Table 1. Dry Eye Severity levels[1, 5]
Dry Eye Severity level1234 (Must have signs and symptoms.)
Discomfort, severity & frequencyMild and/or episodic; occurs under environmental stressModerate episodic or chronic, stress or no stressSevere frequent or constant without stressSevere and/or disabling and constant
Visual symptomsNone or episodic mild fatigueAnnoying and/or activity-limiting episodicAnnoying, chronic and/or constant, limiting activityConstant and/or possibly disabling
Conjunctival injectionNone to mildNone to mild+/–+/++
Conjunctival stainingNone to mildVariableModerate to markedMarked
Corneal staining (severity/location)None to mildVariableMarked centralSevere punctate erosions
Corneal/tear signsNone to mildMild debris, decreased meniscusFilamentary keratitis, mucus clumping, increased tear debrisFilamentary keratitis, mucus clumping, increased tear debris, ulceration
Lid/meibomian glandsMGD variably presentMGD variably presentFrequentTrichiasis, keratinization, symblepharon
TFBUT (sec)Variable≤10≤5Immediate
Schirmer score (mm/5 min)Variable≤10≤5≤2
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.